# Filipa Farinha

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/filipa-farinha/

## Facts

| Field | Value |
| --- | --- |
| Citations | 456 |
| Field | Systemic Lupus Erythematosus Research |
| h-index | 13 |
| i10-index | 16 |
| Last Known Institution | London Centre for Nanotechnology |
| OpenAlex ID | https://openalex.org/A5066566010 |
| ORCID iD | 0000-0002-1517-4383 |
| Works | 63 |

## Researcher papers

- [Epidemiologia da Demência e da Doença de Alzheimer em Portugal: Estimativas da Prevalência e dos Encargos Financeiros com a Medicação](https://scholariq.org/papers/epidemiologia-da-demencia-e-da-doenca-de-alzheimer-em-portugal-estimativas-da/)
- [Contactin-1 links autoimmune neuropathy and membranous glomerulonephritis](https://scholariq.org/papers/contactin-1-links-autoimmune-neuropathy-and-membranous-glomerulonephritis/)
- [Lupus nephritis: a retrospective review of 78 cases from a single center](https://scholariq.org/papers/lupus-nephritis-a-retrospective-review-of-78-cases-from-a-single-center/)
- [Serum Metabolomic Signatures Can Predict Subclinical Atherosclerosis in Patients With Systemic Lupus Erythematosus](https://scholariq.org/papers/serum-metabolomic-signatures-can-predict-subclinical-atherosclerosis-in-patients/)
- [Concerns of patients with systemic lupus erythematosus and adherence to therapy – a qualitative study](https://scholariq.org/papers/concerns-of-patients-with-systemic-lupus-erythematosus-and-adherence-to-therapy/)
- [Outcomes of membranous and proliferative lupus nephritis – analysis of a single-centre cohort with more than 30 years of follow-up](https://scholariq.org/papers/outcomes-of-membranous-and-proliferative-lupus-nephritis-analysis-of-a-single/)
- [Assessing outcomes in a lupus nephritis cohort over a 40-year period](https://scholariq.org/papers/assessing-outcomes-in-a-lupus-nephritis-cohort-over-a-40-year-period/)
- [Survival analysis of mortality and development of lupus nephritis in patients with systemic lupus erythematosus up to 40 years of follow-up](https://scholariq.org/papers/survival-analysis-of-mortality-and-development-of-lupus-nephritis-in-patients/)
- [Fracture risk in systemic lupus erythematosus patients over 28 years](https://scholariq.org/papers/fracture-risk-in-systemic-lupus-erythematosus-patients-over-28-years/)
- [Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus](https://scholariq.org/papers/extent-of-vascular-plaque-predicts-future-cardiovascular-events-in-patients-with/)

## Researcher topics

- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)
- [Rheumatoid Arthritis Research and Therapies](https://scholariq.org/topics/rheumatoid-arthritis-research-and-therapies/)
- [Systemic Sclerosis and Related Diseases](https://scholariq.org/topics/systemic-sclerosis-and-related-diseases/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)
- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)

## Researcher university

- [London Centre for Nanotechnology](https://scholariq.org/institutions/london-centre-for-nanotechnology/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.